Business Strategy(Page)
s by far the most logical approach to meeting that dire medical need. The time to move forward is now. Many statistical studies have indicated...

A utility patent was approved for Medicortex in China(News)
Utility model application No. 201890000516.8 in China (national phase of PCT/IB2018/050698) "NON-INVASIVE BRAIN INJURY DIAGNOSTIC...

Aivovamman tunnistaminen sylkitestillä etenee – turkulainen yritys listautuu pörssiin(News)
Turkulaisen Medicortex Finland Oyj:n kehittämän uudenlaisiin biomerkkiaineisiin perustuvan pikatestin avulla voitaneen pian havaita aivovamma...

Medicortex has published a company release: The Finnish Financial Supervisory Authority has approved a supplement to the Prospectus(News)
e="">Following news about approval of the project plan by the US Department of Defense (...

Why invest?(Page)
otected by several patent applications . Some patents have already been granted. The company has comprehended that there is a huge need for ne...

Approval of a patent for a drug candidate / Lääkemolekyylipatentti hyväksytty(News)
-Finland-Announces-Patent-Approval-Underlying-Technology" class="aloha-link-text" target="_blank">Press Release.Medicortexin lääkem...

Medicortex has published a company release announcing that the US Department of Defense has approved Company’s project plan(News)
ment of Defense (DoD) has approved Company’s project plan to develop a test strip detecting brain injury biomarkers in urine. The Company star...

Technology(Page)
agnostic test can also be applied in cases where there are no external signs of injury, for example for soldiers exposed to blast or explosion...

Tietoa meistä(Page)
callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];...

Medicortex Finland Plc has published a press release regarding announcement of IPO(News)
public offering (IPO) and apply for listing on Nasdaq First North Growth Market Finland. The IPO is to take place 13.-22.6.2022...

Company Profile(Page)
Medicortex Finland Medicortex Finland Oyj was founded in June 2014 as a BioTurku member; it is located in Werstas bioincubator in the heart of...

Reports and presentations (Page)
al information The latest approved Financial statement and auditor's report: Medicortex Tilinpaatos 2022 Medicortex Financial Statement 2022 R...

Medicortex Finland Is Developing Diagnostic Tool Based on Biomarkers for Traumatic Brain Injury and Stroke(News)
Medicortex Finland's new press release is out! Medicortex Finland Oy has started research to establish a biomarker and to develop a diagno...

New key persons joining Medicortex Finland(News)
addition, Medicortex has appointed Mr. Mikko Laurila (M.Sc.Econ) as the Chief Financial Officer (CFO). Read the...

In the press: Turun Sanomat has published an article about Medicortex(News)
's achievement in gaining approval for its project plan from the US Department of Defense (DoD). To read the full article, follow this...

A new Advisor joining Medicortex / Medicortexille uusi neuvonantaja(News)
te/medicortex-finland-plc-appointing-a-new-advisor?publisherId=49600577&releaseId=69959037" class="aloha-link-text" target="_blank">Please...

Suomeksi(Page)
Medicortex suomeksi Medicortex Finland Oyj on tapaturmaisen aivovamman biomerkkiainetutkimukseen erikoistunut yritys. Medicortexin ensimmäinen...

Biomarker R&D program(Page)
TBI and its time-related appearance after the injury, and validation in child patients. Read More2 Illustration Mod2 Future Plans Arrow The d...

Letter from CEO(Page)
e are no accurate, widely approved diagnostic tool to detect TBI unambiguously. Neurological examination of patient’s responses is currently u...

Medicortex Finland Receives an Innovation Grant(News)
injuries. The company is happy to receive this recognition and will use the funds to further the development of its diagnostic kit. The full p...

Art Helping TBI Research(News)
p;We have approached several artists like painters, photographers etc. and asked them to contribute a unique pieces of art ins...

Happy Holidays(News)
hes you Merry Christmas, Happy Hanukkah and Happy New Year 2023!Thank you for your cooperation in 2022...

Tutkimussuunnitelma(Page)
tai muihin neurologisiin rappeumasairauksiin. Toistuvista iskuista ja aivotärähdyksistä kärsivät erityisesti nyrkkeilyn, jääkiekon ja jalkapal...

Board of Directors(Page)
pany’s governance and the appropriate organization of operations. The Board of Directors affirms the principles of the Company’s strategy, org...

Board of Directors(Page)
pany’s governance and the appropriate organization of operations. The Board of Directors affirms the principles of the Company’s strategy, org...

Letter from CEO(Page)
e are no accurate, widely approved diagnostic tools to detect TBI unambiguously. Neurological examination of patient’s responses is currently ...

Medicortex featuring in a premium magazine(News)
Medicortex' approach to solve the issue of traumatic brain injury diagnostics is addressed in the world's most respected Family Office mag...

Happy holidays (News)
cortex team wishes you a happy and relaxing holiday season...

Yhtiökokous(Page)
Medicortexin yhtiökokoukset Varsinainen yhtiökokous 26.4.2024 Medicortex Finland Oyj:n varsinainen yhtiökokous pidetään perjantaina 26.4.2024 ...

Company Profile(Page)
Medicortex Finland Oyj Medicortex Finland Oyj was founded in June 2014 and is located in Werstas bioincubator in the heart of Turku Science Pa...

Medicortex was granted a European patent for COVID-19 diagnostics // Medicortexille myönnetty COVID-19 diagnostiikka patentti Euroopassa(News)
Medicortex's COVID-19 diagnostics patent “Method for Determining Coronavirus and Kit for the Same” was granted in the Eu...

Medicortex was granted a Finnish patent for tissue damage diagnostics // Medicortexille myönnetty patentti Suomessa kudosvaurion havaitsemiseksi(News)
Medicortex's tissue damage diagnostics patent “Method of detecting tissue damage” was granted in Finland (FI patent No. 130428)...

Why Invest?(Page)
roprietary and innovative approach. Protected by Patents: Our groundbreaking biomarker is fully protected by patents. These patents not only...

Medicortex and Dividend Announce a Pre-IPO Investment / Medicortex ja Dividend Julkistavat Ennakko-IPO Sijoituksen(News)
p>Dividend will invest in Medicortex as a part of a pre-IPO round Medicortex is currently conducting...

Articles of Association(Page)
Managing Director who is appointed by the Board of Directors. 6 § REPRESENTATION OF THE COMPANY The Board of Directors represents the Company...

Invest Now(Page)
nt can be sent via email: medicortex@medicortex.fi or mail: Medicortex Finland Oyj, Itäinen Pitkäkatu 4 B, 4th floor, FI-20520 Turku, Finland....

Medicortex Finland Announces Agreement with Pro-Lab / Yhteistyösopimus Pro-Lab:n kanssa(News)
Medicortex has signed a cooperation agreement with a Canadian company Pro-Lab Diagnostics Inc. Please see the...

Medicortex was shortlisted as a finalist to the Europabio´s Most Innovative European Biotech SME Awards(News)
Medicortex was shortlisted as a runner-up to the Most Innovative European Biotech SME Awards competition organized by European Association...

Medicortex Announces Receiving a 1.1 Million Dollars Research Grant from the US Department of Defense / Medicortex Finland Oy:lle tutkimusrahoitusta Yhdysvaltain Puolustusministeriöltä(News)
Medicortex received a 1.1 M$ grant from the US Department of Defense. See...

Medicortex received a 50 k€ grant / Medicortex Finland Oy:lle myönnettiin 50k€ suuruinen kehittämisavustus (News)
Medicortex received a 50 k€ grant from the Finnish Centre for Economic Development, Transport and the Environment to supp...

Medicortex in Newspaper / Medicortex Turun Sanomissa(News)
fi/uutiset/talous/5388950/Medicortex+tavoittelee+listautumista+ensi+vuonna++maailmanvalloituksen+esteena+viela+raha" class="aloha-link-text" t...

Medicortex subscription campaign ends 20.1.2023 // Medicortex osakeanti päättyy 20.1.2023!(News)
the last day to subscribe Medicortex’ shares at the campaign price of 0,50 Euros per share!Huomenna, 20. tammikuuta, on...

Uusi lehdistötiedote: Turun kaupunki myönsi Medicortexille TKI-setelin(News)
Medicortexille myönnettiin 5000 euron arvoinen TKI (tutkimus, kehitys- ja innovaatio-osaaminen) -seteli Turun yliopiston kanssa y...

Medicortex's new brain injury test: share issue 14 - 28 November 2023(News)
Medicortex invites the public to invest in the development of a new brain injury test (TesTBI). Medicortex's fundraising campaign...

Medicortexin osakeanti päättyy huomenna / Medicortex's share issue ends tomorrow(News)
si päivää aikaa sijoittaa Medicortexin uuteen aivovammatestiin! Lisätietoa...

Osallistu webinaariin 7.8.2020(Page)
callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];...

Management(Page)
the CEO and other members appointed by the Board of Directors. Our capable management team consists of three people, including the CEO, CSO, a...

Management(Page)
the CEO and other members appointed by the Board of Directors. Our capable management team consists of three people, including the CEO, CSO, a...

The TBI Market(Page)
osis Each year, there are approximately 69 million new cases of traumatic brain injury (TBI) globally. Of these, 2.8 million are confirmed in ...

Management(Page)
the CEO and other members appointed by the Board of Directors. Our capable management team consists of three people, including the CEO, CSO, a...

Scientific and Clinical Advisory Board had a meeting(News)
29th November. The Board approved the new pediatric clinical study plan. Medicortex will select a Prinicpal Investigator and submit the proto...

Patent issued in Canada / Patentti myönnetty Kanadassa(News)
We are happy to announce that the Canadian Patent Office has granted a patent for our core technology in biomarker diagnostics. Please see...

Art auction(Page)
About this auction Medicortex Finland medico_47c9da6_row_2.png medico_54b8af0_row_3.png Medicortex has started to raise funds for the developm...

Immateriaalioikeudet(Page)
Medicortexin immateriaalioikeudet Medicortexin patentit diagnostiikassa: “Prognostic and Diagnostic Glycan-based Biomarkers of Brain Damage” ...

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland(News)
remarkable milestone for Medicortex. Please see the ...

Tom Palenius joins Medicortex's Board of Directors(News)
Annual General Meeting of Medicortex, held on 29th May 2017, elected Mr. Tom Palenius as the member of the Board of Directors. Mr. Palenius ha...

Mayor of Turku visiting Medicortex / Turun kaupunginjohtaja vierailulla(News)
he City of Turku, visited Medicortex today. Medicortex's projects and background as well as the company's team were presented her. We had plea...

Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury(News)
Medicortex was authorized by the ethical committee to add a new study site to the current clinical trial. The company is now conducting th...

Medicortex Closes Successful Pre-IPO Funding Round(News)
Medicortex successfully completed the pre-IPO share issue. Medicortex is working with a certified advisor from Nordic CA. The IPO is plann...

Annual General Meeting / Yhtiökokous (News)
Annual General Meeting of Medicortex Finland Oy will be held on Wednesday 13 April 2022 at 10:00 a.m. Finnish time, in the premises of...

Medicortex avaa osakeantikampanjan (merkintäaikaa jatkettu 19.7. asti)(News)
ät mukaan.Medicortex Finland Oyj on tänään 1.7.2022 avannut osakeannin. Anti kestää 18.7.2022 asti ja sijoittajat voivat merki...

Medicortex Finland Oyj on julkaissut pörssitiedotteen suunnittelemastaan Listautumisannista(News)
Medicortex on julkaissut pörssitiedotteen, jossa ilmoittaa aikomuksestaan järjestää Listautumisanti ja hakea listautumista Nasdaq...

Medicortex Announces a Fundraising Campaign (extended to 19 July)(News)
t on time.Medicortex Finland Plc has today 1 July 2022 launched a fundraising campaign. The campaign lasts until 18 July 2022...

EU Startup News writes an article about Medicortex(News)
rticle "Startup Showcase: Medicortex Finland Oy – Revolutionizing Brain Injury Diagnosis" about Medicortex. Read more...

Medicortexin uusi aivovammatesti: osakeanti 14.-28.11.2023(News)
Medicortex kutsuu yleisöä sijoittamaan uuden aivovammatestin (TesTBI) kehittämistyöhön. Medicortexilla on käynnissä osakeantikamp...

Proof of concept(Page)
d confirmation for patent applications to protect the novel biomarker idea. Preclinresults 1 Clinical development The first clinical study dem...

Drug development program(Page)
using the one-dimensional approach, intervention must address several pathways, both simultaneously and sequentially, to be effective. Drug de...

Scientific and Clinical Advisory Board(Page)
MO) of Medicortex. He was appointed the Chairman of the Scientific and Clinical Advisory Board in 2023. Professor Kaipia is a specialist in su...

Yhtiöjärjestys(Page)
seen mukainen voitto tai tappio antaa aihetta; 5. vastuuvapaudesta hallituksen jäsenille ja toimitusjohtajalle; 6. hallituksen varsinaisten jä...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous (News)
of June. The board approved the pediatric clinical study. Additionally, a new indication for the biomarker was discussed...

IP rights(Page)
ury Diagnostic Device PCT application WO/2018/154,401, has entered into national phases South African patent (number pending) Utility model gr...

Press Releases(Page)
Medicortex's Press Releases Lehdistötiedotteet (Fin) "Medicortex was granted a Finnish patent related to the detection of tissue damage" - pub...

General Meetings(Page)
Annual General Meeting of Medicortex Finland Plc will be held on Friday 26 April 2024 at 2 p.m. (Finnish time) in company's premises in Turku,...

Medicortex received an innovation award(News)
kström foundation awarded Medicortex an innova...

Newsletter 2/2017: Three questions about the Medicortex's idea(News)
Medicortex's crowdfunding at Invesdor is going on and we have received a lot of questions regarding the idea. We would like to answer three ma...

Military accidents can be diagnosed using Medicortex's kit - A new press release(News)
raumatic stress disorder. Medicortex's kit can help to find the actual reason for their problems...

Article in Turun Sanomat about Medicortex Finland Oy / Turun Sanomissa artikkeli Medicortexista(News)
rticle and interview with Medicortex team.Turun Sanomissa oli tänään artikkeli ja haastattelu Medicortexista...

Medicortex was accepted to the European Union Horizon 2020 funding program (News)
Medicortex was accepted to the first phase of the European Union...

Medicortex is featured in Good News from Finland / Medicortex näkyvästi esillä Good News from Finland -sivustolla(News)
Medicortex is one of a few Finnish beneficiaries of the 50,000-euro grant from the European Innovation Council. See an article on...

Medicortex - SME of the Month in January. Read the interview by Europabio. (News)
Medicortex was chosen as a...

Medicortex featuring in Turun Sanomat newspaper / Medicortex Turun Sanomissa(News)
u published an article on Medicortex. ...

Medicortex presenting in an investors seminar / Medicortex esiintyi Turussa sijoittajatapahtumassa (News)
Medicortex was presenting in Turku to members of investors federation (https://www.osakeliitto.fi/...

Happy Easter and happy Passover(News)
Happy Easter and happy Passover to all our friends! ...

Medicortex was accepted into the Nordic Health Tech Talents program (News)
Medicortex team is pleased to be a part of the Danish Nordic Health Tech Talents program. See their web site: ...

Medicortex was chosen as the winner of TechBBQ’s pitching competition! (News)
Medicortex team was visiting Copenhagen and participated in TechBBQ´s pitching competition 19th of September. Medicortex team i...

Medicortex featured in a news podcast (News)
d="document_0_112" title="Medicortex Interview From Jerusalem With Love">Medicortex Interview From Jerusalem With Love...

Merkittävä saavutus – Medicortexille myönnettiin patentti Yhdysvalloissa (News)
titoimisto (USPTO) myönsi Medicortexin patentin Yhdysvalloissa, mikä suojaa yrityksen diagnostista testiä ja innovatiivista biomerkkiaine tekn...

Business Finland myönsi rahoitusta Medicortexille(News)
Medicortexille myönnettiin rahoitusta Business Finlandilta, mikä tukee pikatestin kehitysprojektin jatkamista. ...

Business Finland Granted Funding for Medicortex(News)
iness Finland has granted Medicortex with funding which supports the continuation of the diagnostic test development project. ...

Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland(News)
Medicortex has completed the sample collection phase of the third clinical trial. In the trial children and adolescents were recruited who...

Medicortex on saanut kerättyä kaikki potilaat kolmanteen kliiniseen tutkimukseen (News)
Medicortex keräsi sylkeä ja virtsaa aivotärähdyksen saaneilta lapsilta ja nuorilta yhteistyössä Porin Satasairaalan kanssa. Potilaita kerä...

Medicortexin ilmoitus Virallisessa Lehdessä(News)
essa Lehdessä on ilmoitus Medicortex osakkeiden liittämisestä arvo-osuusjärjestelmään.Lue Virallinen Lehti...

Muistutus osakkeiden siirtämisestä arvo-osuusjärjestelmään(News)
Medicortexin osakkeita ollaan siirtämässä sähköiseen arvo-osuusjärjestelmään. Lähetimme osakkaille 28.1.2022 tiedotteen ja toimin...

Medicortex Signed a 2 Million Dollars Research Grant Contract with the US Department of Defense(News)
Medicortex Finland Plc announces that the US Department of Defense (“DoD”) has awarded the company a research grant of about...

Medicortex sopimukseen 2 miljoonan dollarin tutkimusrahoituksesta Yhdysvaltain puolustusministeriön kanssa(News)
Medicortex Finland Oyj tiedottaa, että Yhdysvaltain puolustusministeriö (US Department of Defense, ”DoD”) on myöntänyt yhtiölle noin 2 mil...

Good News from Finland writes an article about Medicortex(News)
from Finland writes about Medicortex' success in gaining a second grant from US DoD in their article "Finnish firms seek better therapies". Re...

Good News from Finland kirjoittaa artikkelin Medicortexista(News)
s from Finland kirjoittaa Medicortexin menestyksestä toisen rahoituksen saamisessa Yhdysvaltain puolustusministeriöltä artikkelissaan "Finnish...

Medicortex has published a press release regarding the outcome of the fundraising campaign(News)
Medicortex has published a press release announcing the outcome of the January fundraising campaign. Read more...

Medicortex on julkaissut lehtiötiedotteen: talven osakeantikampanja on saatu päätökseen(News)
Medicortex on saanut päätökseen tammikuun osakeantikampanjan. Lue lehtiötiedote...

Medicortex's new press release: the outcome of the two fundraising rounds(News)
Medicortex has published a press release announcing the outcome of the two rounds of a fundraising campaign that took place in the first h...

Medicortexin uusi lehtiötiedote: osakeantikampanjan toinen kierros päättynyt(News)
Medicortex on saanut päätökseen vuoden 2023 ensimmäisen puolikkaan aikana pidetyn osakeantikampanjan toisen kierroksen. Lue lehti...

Medicortex's share issue 17.-31.8.2023(News)
Medicortex has a share issue campaign 17.-31.8.2023 during which each share subscribed entitles to one free option. See details...

Medicortexin osakeantikampanja 17.-31.8.2023(News)
Medicortexilla on käynnissä osakeantikampanja 17.-31.8.2023, jonka aikana jokaista merkittyä osaketta kohti merkitsijä saa yhden...

Medicortexin esittelytilaisuus(News)
" class="aloha-link-text">medicortex@medicortex.fi tai soittamalla +358 400 870 366.Yhtiön esittelytilaisuuden ohjelma:...

Medicortex was granted a European patent for biomarker diagnostics(News)
Medicortex's biomarker diagnostics patent “A Method for Determining a Lectin-binding Glycan Indicative to Traumatic Brain Injury”...

Medicortex receives extension to Business Finland funding decision(News)
Medicortex announces receiving an extension for raising the starting equity required by the funding decision from Business Finland. The fu...

Medicortex saa jatkoaikaa Business Finlandin rahoituspäätökselle(News)
Medicortex on saanut jatkoaikaa Business Finlandin rahoituspäätöksen edellyttämän alkupääoman keräämiseen. Varat käytetään tapaturmaisen a...

Second clinical trial(Page)
TBI and its time-related appearance after the injury. Second clinical trial...

Medal award ceremony for Dr. Mårten Kvist(News)
e’s Work and a diploma as appreciation to his achievements...

Investors(Page)
for additional investors Medicortex Finland Plc is giving current shareholders as well as new investors the opportunity to invest in the comp...

Raportit ja esitykset(Page)
Yhtiöesite: Medicortex Yhtioesite Tammikuu 2024 Yhtiön PowerPoint-esitys: Medicortex Ppp Huhtikuu 2024 Merkintäsopimus: 2024 Q2 Merkintasopimu...

Miksi sijoittaa?(Page)
Medicortex kehittää Suomessa uutta menetelmää suureen tarpeeseen eli tapaturmaisen aivovamman diagnostiikkaan Sijoitukset käytetään kliinisiin...

Lehdistötiedotteet(Page)
Medicortexin lehdistötiedotteet - julkaistu 28.8.2023. - julkaistu 18.8.2023. - julkaistu 12.7.2023. - julkaistu 15.6.2023. - julkaistu 30.5.2...

Medicortex Finland Held Discussions with TEKES(News)
Medicortex Finland's staff was in Helsinki on the 7th of March to discuss a long-term loan with the ...

Medicortex is attenting BAF Live! in April(News)
l & Mårten Kvist from Medicortex Finland are attending the...

Medicortex presenting at the Sport Concussion Symposium in Helsinki(News)
text" target="_blank">Medicortex will have a poster presentation in the Symposium...

Medicortex Finland featured on The Bio Connection(News)
Medicortex Finland's was featured on March 28th on The Bio Connection news site. You can read the article in full...

Medicortex's Annual General Meeting on May 30th(News)
Medicortex's annual general meeting will take place in the Turku Science Park Bioincubator on the 30th of May. All shareholders are invite...

The First Clinical Trial is Approaching(News)
Medicortex is planning to conduct a clinical trial in the Q4 of 2016. The presence and the profiles of the unique biomarkers will be studi...

Press release: A clinical trial is a significant accomplishment for Medicortex(News)
ficant-accomplishment-for-medicortex?publisherId=49600577&releaseId=50277257" class="">press release about the clinical trial...

Medicortex Featured in Local Newspaper, Turun Sanomat(News)
Medicortex's Adrian Harel & Mårten Kvist were interviewed by Turun Sanomat during the holiday season. Dr. Harel discussed the...

Medicortex has completed collection of clinical samples(News)
We are happy to announce that we have completed the collection of clinical TBI patient samples in collaboration with Turku University Hosp...

Medicortex has launched a crowdfunding campaign(News)
Medicortex has started a crowdfunding campaign to finance the next phase development of the brain injury test. You can help us to develop...

Medicortex Finland using crowdfunding to help develop brain injury diagnostics(News)
/pressreleasejet.com/news/medicortex-finland-using-crowdfunding-to-help-develop-brain-injury-diagnostics.html" class="aloha-link-text" target=...

Medicortex's Annual General Meeting on May 29th(News)
Medicortex's Annual General meeting will take place in The Turku Science Park Bioincubator on the 29th of May 2017 at 15:00. All current s...

Happy New (Jewish) Year!(News)
Contacts and Investors - Happy New (Jewish) Year!...

Medicortex participated in a press conference #pääasia(News)
Medicortex's medical director Mårten Kvist participated on a panel discussion of #pääasia- media event 7.11. in Biocity Turku. Fo...

Happy New (Jewish) Year!(News)
Contacts and Investors - Happy New (Jewish) Year!...

Medicortex presentation in Monaco (News)
by Dr. Adrian Harel from Medicortex Finland Oy in Monaco (September 28, 2018 - Novotel Monte Carlo).For more information and sign...

Medicortex hakee tuotekehityspäällikköä(News)
Medicortex etsii tuotekehityspäällikköä, joka tulee vastaamaan lääketieteellisen testin kehityksestä ja testikasetin suunnittelusta. Lisät...

Medicortex Turun Sanomissa: "Turkulaisyritykselle yli miljoonan dollarin tutkimusrahoitus Yhdysvaltain puolustusministeriöltä"(News)
Medicortex Turun Sanomissa: ...

Medicortex in Science and Enterprise(News)
d Enterprise about Medicortex and the R&D grant from the US Department of Defense...

Medicortex featured in The Jerusalem Post(News)
">Dr Adrian Harel, CEO of Medicortex was interviewed by Eytan Halon from The Jerusalem Post. See the article: "...

Medicortex featured in an Israeli newspaper, News1 (News)
Read about Medicortex in “A revolutionar...

Medicortex wins the Life Science Pitching competition at Y Science 2019 (News)
Medicortex participated in Life Science pitching competition at...

Medicortex presented at LSX World Congress in London(News)
he recent developments at Medicortex to the leaders of life science industry. LSX World Congress brings together the healthcare exec...

A clinical trial for children started / Kliininen tutkimus lapsipotilaille alkanut(News)
Medicortex has started its third clinical trial at Satasairaala hospital in Pori, Finland. This trial will focus on children and adolescen...

Medicortex CEO, Dr Adrian Harel participated in a pitching to Finnish business angels(News)
arel was invited to pitch Medicortex for FiBAN, the Finnish business angels’ network. Adrian presented the company in a webinar due...

Medicortex Finland Oy Announces Issuance of a Patent for Brain Injury Biomarker(News)
ws/home/20200415005854/en/Medicortex-Finland-Oy-Announces-Issuance-Patent-Brain" class="aloha-link-text" target="_blank">See press release...

Medicortexista artikkeli Turkun Sanomissa. (News)
at julkaisivat artikkelin Medicortexista. ...

Medicortex is looking for new investors (News)
at our investor’s page for more information. ...

Medicortex Announces Progression in the Clinical Trial for Detection of Mild Traumatic Brain Injury in Children(News)
://www.sttinfo.fi/tiedote/medicortex-finland-oy-announces-the-progression-of-clinical-trial-for-detection-of-mild-traumatic-brain-injury-in-ch...

Medicortex Finland Oy announces reaching the halfway point in the clinical trial for children and adolescents.(News)
://www.sttinfo.fi/tiedote/medicortex-finland-oy-announces-the-advancement-in-clinical-trial-for-detection-of-mild-traumatic-brain-injury-in-ch...

Medicortex in a Swedish Newspaper (News)
Medicortex was featured in Swedish newspaper Åbo Underrättelser in the article: "Åboföretag utvecklade "slickepinne" som ska diag...

Turun Sanomat kirjoitti artikkelin Medicortexista (News)
un Sanomat julkaisi jutun Medicortexin patentista, joka juuri myönnettiin Israelissa. Lue artikkeli...

Extraordinary general meeting / Ylimääräinen yhtiökokous (News)
Medicortex is organizing an extraordinary general meeting which will be held on 14th January 2022 at 13:00 p.m. in company's prem...

Medicortex featured in Good News From Finland (News)
in Finland which features Medicortex. Read the article...

Extraordinary General Meeting / Ylimääräinen yhtiökokous(News)
Medicortex is organizing an Extraordinary General Meeting which will be held on 31 March 2022 at 1 p.m. in company's premises in...

Medicortex on julkaissut yhtiötiedotteen, jossa ilmoittaa Yhdysvaltain puolustusministeriön hyväksyneen hankesuunnitelman(News)
Medicortex tiedottaa, että Yhdysvaltain puolustusministeriö (US Department of Defense, ”DoD”) on hyväksynyt Yhtiön hankesuunnite...

Medicortex on julkaissut yhtiötiedotteen: Finanssivalvonta on hyväksynyt Esitteen täydennyksen(News)
href="https://sijoittajat.medicortex.fi/" class="aloha-link-text" target="_blank">Listautumisanti-sivulta.Lue lisää:...

Medicortex lehdistössä: Turun Sanomat julkaissut artikkelin(News)
on julkaissut artikkelin Medicortexin projektisuunnitelman hyväksynnästä ja mahdollisen apurahan saannista Yhdysvaltain puolustusministeriölt...

Medicortex has published a company release: IPO and listing cancelled(News)
Medicortex announces cancellation of the Initial Public Offering (IPO) and listing to the First North Growth Market Finland...

Medicortex on julkaissut yhtiötiedotteen: listautumisanti ja listautuminen perutaan(News)
Medicortex ilmoittaa päätöksestään perua listautumisannin ja listautumisen Nasdaq Helsinki Oy:n ylläpitämälle First North Growth...

Ilta-Sanomat on julkaissut artikkelin Medicortexista(News)
on julkaissut artikkelin Medicortexin aivovammojen havaitsemiseen tarkoitetun pikatestin kehitystyöstä. Lue koko artikkeli...

Medicortex is having a campaign 5 – 20 January 2023(News)
our investors page...

Medicortex järjestää osakeannin 5.-20.1.2023(News)
saat sijoittajat sivultamme...

Medicortex had a Workplace Well-being day!(News)
style="">On 2nd of March, Medicortex had a workplace well-being day which included several activities for team bonding and some for educationa...

Medicortex has a fundraising campaign 10-24.5.2023(News)
our investors page...

Medicortex järjestää osakeannin 10.-24.5.2023(News)
saat sijoittajat sivultamme...

Hallitus(Page)
johtaja, toimitusjohtaja, Medicortexin perustaja Hallituksen jäsen vuodesta: 2014 Koulutus: Neurobiologian tohtori (Weizmann Institute of Scie...

Hallitus(Page)
johtaja, toimitusjohtaja, Medicortexin perustaja Hallituksen jäsen vuodesta: 2014 Koulutus: Neurobiologian tohtori (Weizmann Institute of Scie...

Scientific advisory board gather together first time in a new composition (News)
Medicortex Finland Oy scientific advisory board gather together first time with a new composition. We had active di...

Jonne Virtanen lähti bioteknologiayhtiön mainoskasvoksi – ”Hiljaista epidemiaa esiintyy urheilujoukkueissa”(News)
tuvan bioteknologiayritys Medicortexin mainoskasvona. Pörssiin listautumassa olevan turkulaisyrityksen kehittämän pikatestin avulla voitaneen...

Traumatic brain injury (Page)
sing mild TBI. Inadequate approaches to diagnosing mild TBI creates a need for significant improvement in the detection and classification of ...

The second brain injury awareness meeting 12.2.2018(News)
eness evening was held in Medicortex premises on February 12th 2018. Dr. Lauri Kangas, Member of the Scientific Advisory Board, opened the eve...

Patent Issued in Israel / Patentti Israelissa(News)
Patent Office has issued Medicortex a patent on Company's chemical compounds for the drug development program. Please see our...

Vielä vähän aikaa kerätä Business Finland-päätöksen alkupääoma!(News)
Medicortexilla on maaliskuun loppuun asti aikaa kerätä 200.000 Euron alkupääoma Business Finland -rahoituksen aktivoimiseksi. Jos yht...

Still a little time left to raise Business Finland decision's initial capital!(News)
Medicortex has until the end of March to raise initial capital of 200,000 Euros to activate Business Finland funding. If the comp...

Ota yhteyttä(Page)
ta yhteyttä ja kysy lisää Medicortex Finland Oy PharmaCity Itäinen pitkäkatu 4 B, 4. kerros 20520 Turku Finland Tel. +358 (0)400 488 817  medi...

Press releases(Page)
s - published 27.2.2024. "Medicortex was granted a European patent for detection of biomarker indicative to brain injury" - published 24.1.202...

Professor Asla Pitkänen is the Neuroscientist of the Year(News)
Member of the Medicortex's Scientific Advisory Board, Professor Asla Pitkänen was awarded a title of Neuroscientist of the...

New Clinical Trial Started / Kliininen tutkimus alkanut(News)
Medicortex announces that the first subject has been enrolled in the new clinical trial. Please see the...

Clinical Trial Completed / Kliininen tutkimus päättynyt(News)
Medicortex has completed the recruitment of patients and collection of their body fluid samples in its second clinical trial. Next, compre...

Press Release / Lehdistötiedote(News)
vtal-om-agarspridning-med-medicortex-87365" class="aloha-link-text" target="_blank">Press Release concerning Medicortex.Mediocortex...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous(News)
Medicortex' Scientific and Clinical Advisory Board convened on 28th of March. The board discussed the company...

Sijoittajat(Page)
ö hakee uusia sijoittajia Medicortex Finland Oyj antaa nykyisille sekä uusille sijoittajille mahdollisuuden sijoittaa yhtiöön ja täten olla mu...

Lehdistötiedotteet(Page)
 - julkaistu 27.2.2024. "Medicortex was granted a European patent for detection of biomarker indicative to brain injury"  - julkaistu 24.1.20...

Crowdfunding successfully completed / Joukkorahoituskampnaja päättynyt(News)
Medicortex has reached the target amount in the crowdfunding campaign using Invesdor's platform. We have more than 80 new shareholders sup...

Scientific Advisory Board (SAB) had a meeting(News)
p>The Scientific Advisory...

A New Clinical Trial for a Novel Brain Injury Biomarker(News)
Medicortex Finland Oy was granted clearance to begin a multi-center clinical trial. The trial will consist of patients that are admitted t...

Haastattelu Aivovammaliiton lehdessä / Interview in the magazine of Brain Injury Association (News)
vammaliitto.fi/wp-content/uploads/2018/03/Aivoitus-1_18-netti.pdf" class="aloha-link-text" target="_blank">haastattelussa. ...

Third study site has been added to the clinical trial (News)
ct2/show/NCT03306563?term=medicortex&rank=1" class="aloha-link-text" target="_blank">ClinicalTrials database. Vaasa central hospi...

Investors’ event in Tampere / Sijoittaja-tapahtuma Tampereella(News)
Medicortex participated in an investors meeting in Tampere on 13.2. The event was organized by Good Marketing Oy. The event was w...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous(News)
Medicortex' Scientific and Clinical Advisory Board convened on 11th of March. The board discussed the 1st...

Annual General Meeting on 28th May 2021 / Varsinainen yhtiökokous 28.5.2021(News)
Medicortex Finland Oy’s Annual General Meeting will be held on 28th May 2021 at 3.00 p.m. in Turku, Finland. An invitation with a...

Patent granted in Israel(News)
One of Medicortex´s patents, “Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage”, was granted in Israel (IL paten...

Articles(Page)
w article compiled by the Medicortex team on the diagnostic biomarkers of TBI. Harel Et Al 2016 Biomarkers Of Tbi  Published in International ...

Tietoa aivovammoista(Page)
staa muihin neurologista rappeutumista aiheuttaviin sairauksiin sairastumiselle myöhemmällä iällä. Toistuvista lievistä aivotärähdyksistä kärs...

Clinical trials(Page)
s later in 2017. Phase II Medicortex is running and planning the following clinical trials. Clinical trials...

Aivovammojen diagnostiikka (Page)
näköisyys kroonisten aivorappeumatautien, kuten Alzheimerin tai Parkinsonin taudin aikaiselle ilmaantumiselle. Lisäksi CT-kuvaus altistaa poti...

Videos (Page)
he sideline: See here how Medicortex kit would benefit active young adults and professional athletes: Or how it would benefit the military per...

Investor relations(Page)
8 817 Email: adrian.harel@medicortex.fi Investor relations...

Product to be Developed(Page)
ll be developed to detect Medicortex's propietary biomarkers from urine samples. TesTBI has four components: A. Electrochemical detection - us...

Sijoittajasuhteet(Page)
Sähköposti: adrian.harel@medicortex.fi Sijoittajasuhteet...

Financial and Developmental Timeline(Page)
roject is estimated to be approximately 1.1 million Euros. In the current fundraising, the goal is to raise up to 100 000 € to cover the cost ...

Dr. Harel is the Face of the Month in Turku Science Park's Newsletter(News)
in Turku a company called Medicortex Finland which develops drugs for reducing the impacts of traumatic brain injury and diagnostics for deter...

Dr. Harel Is Attending Biotech and Money London 2016 (News)
arel will be representing Medicortex Finland in the UK as he is attending the 2nd annual Biotech and Money event in London. The event takes pl...

Dr. Adrian Harel Presented TBI at Life Sciences Israel 2015(News)
n 18th and 19th February. Medicortex Finland and Traumatic Brain Injury were presented. The event page can be found ...

Extraordinary general meeting 29th September(News)
details from adrian.harel@medicortex.fi...

BAF Live! in Helsinki 22nd October 2015(News)
etventure.com/en/projects/medicortex-finland-oy#.ViiugX4rLIU" class="" target="_blank">the company pitch page here. ...

Drs. Harel & Kvist attended the BAF Live! event in Helsinki on 22nd of October(News)
he event was a success as Medicortex was the first company to present itself and the company is ranked #1 in the event's social media activity...

The 24th Annual Israel Society for Neuroscience Meeting(News)
New Multi-Functional Drug Approach for the Treatment of Brain Injury. See more at h...

A review article was published(News)
The Medicortex team has written a scientific review article focusing on the latest research on TBI biomarkers. The article was published i...

Dr. Harel presenting at ESTES Congress 2017(News)
Medicortex's poster abstract has been nominated for the Best Poster Award in the...

Development of the brain injury test sped up by crowdfunding(News)
clinical trial encouraged Medicortex to move on to the next phase in the diagnostic kit development program. We are raising money through the...

An interview published(News)
ity got interested in the Medicortex's clinical activities. Please see Dr. Harel being interviewed by...

Onnea satavuotias Suomi!(News)
tsenäisyyspäivää kaikille Medicortexin seuraajille ja omistajille! Upeat 100 itsenäistä vuotta ovat tehneet Suomesta maailman parhaan paikan e...

Annual General Meeting on 30th May / Varsinainen yhtiökokous 30.5.(News)
Medicortex's Annual General Shareholders' meeting will be held on 30th May 2018 at 3.00 p.m. in the premises of the company in Tu...

Annual General Meeting on 29th May / Varsinainen yhtiökokous 29.5.(News)
Medicortex' Annual General Shareholders' meeting will be held on 29th May 2019 at 3.00 p.m. in the premises of the company in Tur...

Annual General Meeting held / Yhtiökokous pidetty(News)
bility Companies Act. The approved Financial Statement of 2018 is available...

En hjärnskakning, hur allvarlig är en sådan egentligen? / A concussion, how serious is one really?(News)
an egentligen?"Medicortex featured in a Swedish post "A concussion, how serious is one really?"...

CEO, Dr Adrian Harel discusses diagnosing sport concussions in a sport medicine radio talk show with Dr Robert Weil(News)
CEO of Medicortex, Dr. Adrian Harel was interviewed by Dr Robert Weil (The sport doctor) from BBS radio, a sport medicine talk show...

Annual General Meeting on 29th May 2020 / Varsinainen yhtiökokous 29.5.2020(News)
Medicortex's Annual General Meeting will be held on 29th May 2020 at 3.00 p.m. in Turku, Finland. An invitation with annexes has...

Annual General Meeting held / Yhtiökokous pidetty(News)
bility Companies Act. The approved Financial Statement of 2019 is available...

Live Webinaari 7.8.2020(News)
Katso nauhoite Medicortexin järjestämästä live webinaarista. ...

Major achievement – A patent was issued in the United States (News)
://www.sttinfo.fi/tiedote/medicortex-finland-oy-announces-issuance-of-a-patent-in-the-united-states?publisherId=49600577&releaseId=6988930...

Share price now 6.40 euro / Osakkeen hinta nyt 6,40 euroa(News)
le -sivui...

Results of the First Clinical Study are Published in Frontiers in Biomarkers of Brain Injury(News)
="">An article written by Medicortex is accepted into a special issue, the Frontiers in Biomarkers of Brain Injury of the Brain Sciences journ...

CEO, Dr. Adrian Harel interviewed on a medicine radio talk show (News)
CEO of Medicortex, Dr. Adrian Harel was interviewed by Dr Bob Weil (The sport doctor) from BBS radio, a sport medicine talk show...

Uutinen Turun Sanomissa / News in Turun Sanomat(News)
kaa kehittävä turkulainen Medicortex sai uusia osakkaita...

Annual General Meeting(News)
ials here...

Varsinainen yhtiökokous(News)
ytyy täältä...

Results of the Third Clinical Study are Published in the Journal Diagnostics(News)
="">An article written by Medicortex has been published in a peer-reviewed journal Diagnostics. The article summarizes results from the third...

Kolmannen kliinisen tutkimuksen tulokset on julkaistu tieteellisessä Diagnostics-lehdessä(News)
Medicortexin kirjoittama artikkeli on julkaistu vertaisarvioidussa Diagnostics-lehdessä. Artikkeli raportoi kolmannen kliinisen t...

Varsinainen yhtiökokous(News)
ytyy tä...

Annual General Meeting(News)
rong>here...

Reminder to register attendance for AGM(News)
tion here...

Kansanterveys-julkaisu esittelee Medicortexin mahdollisuuksia(News)
...

Press release: Medicortex Finland Oy hakee rahoitusta aivovammatestin kehittämiseen(News)
Please see our press release...

Medicortex presentation in Monaco (News)
Dr. Harel will be presenting at an investors meeting in Monaco. For more information please look at the link. ...

Detecting sport concussions with a disposable quick-test developed by Medicortex (News)
Take a look at our latest video about sport concussions. Returning to play after a concussion can have life-changing consequences. However...

Happy New (Jewish) Year!(News)
...